Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Teva Pharmaceuticals Ireland on risk of medication errors due to the introduction of 2 mg/ml concentration:
New concentration: 2 mg/ml vial to replace current approved 1 mg/ml glass ampoule of TRISENOX
Important Safety Information - TRISENOX (arsenic trioxide)